Memphis Pharmaceuticals & Chemical Industries reported earnings results for the half year ended December 31, 2022. For the half year, the company reported sales was EGP 302.65 million compared to EGP 257.23 million a year ago. Net income was EGP 27.56 million compared to EGP 9.58 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
79.64 EGP | -0.80% | -16.39% | +27.00% |
1st Jan change | Capi. | |
---|---|---|
+27.00% | 9.52M | |
+29.98% | 682B | |
+30.34% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.21% | 240B | |
+9.66% | 209B | |
-6.83% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- MPCI Stock
- News Memphis Pharmaceuticals & Chemical Industries
- Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2022